Evidence map›Paper›PMID 19246389›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice.

Zoita Andronache, Susan L Hamilton, Robert T Dirksen, Werner Melzer

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 61 citations in OpenAlex.

  1. Pathogenic CaCommunications biology · 2026
    Article
  2. Article
  3. Article
  4. Heat-hypersensitive mutants of ryanodine receptor type 1 revealed by microscopic heating.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Molecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. CaCells · 2019
    Review
  10. Excessive Accumulation of CaFrontiers in physiology · 2019
    Article
  11. Review
  12. Voltage modulates halothane-triggered CaThe Journal of general physiology · 2018
    Article
  13. Review
  14. Review of RyR1 pathway and associated pathomechanisms.Acta neuropathologica communications · 2016
    Review
  15. Article
  16. Article
  17. Malignant hyperthermia: a review.Orphanet journal of rare diseases · 2015
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zoita AndronacheInstitute of Applied Physiology, Ulm University, D-89069 Ulm, Germany.
Susan L Hamilton
Robert T Dirksen
Werner Melzer
Baylor College of Medicine · USUniversity of Rochester Medical Center · US

Funding

Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core DiseaseR01AR053349 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI DIRKSEN, ROBERT T, HAMILTON, SUSAN L · 2006 to 2020
$8.0M
Control of Calcium Movements in MuscleR01AR044657 · NIAMS · UNIVERSITY OF ROCHESTER · PI DIRKSEN, ROBERT T · 2002 to 2011
$3.3M
Nitrosylation and Oxidation of RYR1 in Muscle FunctionR01AR050503 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI HAMILTON, SUSAN L · 2004 to 2008
$2.0M
CONTROL OF CALCIUM MOVEMENTS IN MUSCLER29AR044657 · NIAMS · UNIVERSITY OF ROCHESTER · PI DIRKSEN, ROBERT T · 1997 to 2001
$215k
NIAMS NIH HHS AR050503NIAMS NIH HHS AR44657NIAMS NIH HHS AR53349NIAMS NIH HHS R01 AR044657NIAMS NIH HHS R01 AR050503NIAMS NIH HHS R01 AR053349NIAMS NIH HHS R29 AR044657
6 · The paper itself

Abstract

Malignant hyperthermia (MH) is a life-threatening hypermetabolic condition caused by dysfunctional Ca(2+) homeostasis in skeletal muscle, which primarily originates from genetic alterations in the Ca(2+) release channel (ryanodine receptor, RyR1) of the sarcoplasmic reticulum (SR). Owing to its physical interaction with the dihydropyridine receptor (DHPR), RyR1 is controlled by the electrical potential across the transverse tubular (TT) membrane. The DHPR exhibits both voltage-dependent activation and inactivation. Here we determined the impact of an MH mutation in RyR1 (Y522S) on these processes in adult muscle fibers isolated from heterozygous RyR1(Y522S)-knock-in mice. The voltage dependence of DHPR-triggered Ca(2+) release flux was left-shifted by approximately 8 mV. As a consequence, the voltage window for steady-state Ca(2+) release extended to more negative holding potentials in muscle fibers of the RyR1(Y522S)-mice. A rise in temperature from 20 degrees to 30 degrees C caused a further shift to more negative potentials of this window (by approximately 20 mV). The activation of the DHPR-mediated Ca(2+) current was minimally changed by the mutation. However, surprisingly, the voltage dependence of steady-state inactivation of DHPR-mediated calcium conductance and release were also shifted by approximately 10 mV to more negative potentials, indicating a retrograde action of the RyR1 mutation on DHPR inactivation that limits window Ca(2+) release. This effect serves as a compensatory response to the lowered voltage threshold for Ca(2+) release caused by the Y522S mutation and represents a novel mechanism to counteract excessive Ca(2+) leak and store depletion in MH-susceptible muscle.

Indexed as

Mutation, MissenseSignal TransductionAnimalsCalciumCalcium Channels, L-TypeElectrophysiologyGene Knock-In TechniquesIntracellular MembranesMalignant HyperthermiaMembrane PotentialsMiceMice, Mutant StrainsMuscle Fibers, SkeletalMuscle, SkeletalRyanodine Receptor Calcium Release ChannelCalciumCalcium Channels, L-TypeRyanodine Receptor Calcium Release Channel

Identifiers

PMID19246389
PMCPMC2657461
OpenAlexW2083244884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.